Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
Eli Lilly
LLY
$1.11T
| $17.4M | 0.03% |
150,000
+50,000
| +50% | +$5.59M |
|
777
Dave & Buster's
PLAY
$362M
| $17.3M | 0.03% |
388,936
+159,860
| +70% | +$8.99M |
|
778
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$45.4B
| $17.3M | 0.03% |
200,000
+61,000
| +44% | +$5.52M |
|
|
KL
779
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $17.3M | 0.03% |
662,297
-872,822
| -57% | -$18.5M |
|
780
ITT
ITT
$18.3B
| $17.2M | 0.03% |
356,103
+217,573
| +157% | +$11.5M |
|
781
First Bancorp
FBP
$4.31B
| $17.2M | 0.03% |
1,998,527
+522,774
| +35% | +$4.67M |
|
|
HZNP
782
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $17.2M | 0.03% |
879,045
+240,458
| +38% | +$4.71M |
|
783
CBRE Group
CBRE
$44B
| $17.2M | 0.03% |
428,474
+414,562
| +2,980% | +$17.1M |
|
|
FPAC.U
784
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $17.2M | 0.03% |
1,700,000
| – | – |
|
785
Encompass Health
EHC
$11.9B
| $17.1M | 0.03% |
348,709
-429,048
| -55% | -$24.4M |
|
786
DXC Technology
DXC
$1.7B
| $17M | 0.03% |
319,831
-923,369
| -74% | -$63.8M |
|
787
CarGurus
CARG
$3.31B
| $17M | 0.03% |
503,479
+264,060
| +110% | +$10.6M |
|
|
FLG
788
Flagstar Bank National Association
FLG
$5.57B
| $17M | 0.03% |
+601,052
| New | +$17.5M |
|
789
CME Group
CME
$100B
| $16.9M | 0.03% |
90,000
-349,561
| -80% | -$64.6M |
|
790
Nabors Industries
NBR
$1.31B
| $16.9M | 0.03% |
169,002
+104,322
| +161% | +$23M |
|
791
Comfort Systems
FIX
$56.7B
| $16.9M | 0.03% |
386,817
+16,627
| +4% | +$851K |
|
792
Gildan
GIL
$10.2B
| $16.8M | 0.03% |
553,907
+351,668
| +174% | +$10.9M |
|
793
Digital Realty Trust
DLR
$69.8B
| $16.8M | 0.03% |
157,677
+42,858
| +37% | +$4.74M |
|
794
Jacobs Solutions
J
$17.7B
| $16.7M | 0.03% |
346,000
-662,580
| -66% | -$37.9M |
|
795
EPAM Systems
EPAM
$5.74B
| $16.7M | 0.03% |
144,164
-58,783
| -29% | -$7.21M |
|
|
CIT
796
DELISTED
CIT Group Inc.
CIT
| $16.7M | 0.03% |
435,863
-1,153,945
| -73% | -$52.4M |
|
|
CLDR
797
DELISTED
Cloudera, Inc.
CLDR
| $16.7M | 0.03% |
1,506,085
+371,107
| +33% | +$4.94M |
|
798
MKS Inc
MKSI
$18.2B
| $16.6M | 0.03% |
257,444
-28,622
| -10% | -$2.07M |
|
|
QVCGA
799
DELISTED
QVC Group Inc Series A
QVCGA
| $16.6M | 0.03% |
17,545
+13,040
| +289% | +$13.7M |
|
800
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $16.6M | 0.03% |
100,000
-1,000
| -1% | -$173K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.